Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis-Reference-Cited by-同舟云学术

Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

Published:2015-06-04 Issue:8 Volume:35 Page:725-734
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenat Diagn

Author:

Benn Peter¹,Borrell Antoni²,Chiu Rossa W. K.³,Cuckle Howard⁴,Dugoff Lorraine⁵,Faas Brigitte⁶,Gross Susan⁷,Huang Tianhua⁸,Johnson Joann⁹,Maymon Ron¹⁰,Norton Mary¹¹,Odibo Anthony¹²,Schielen Peter¹³,Spencer Kevin¹⁴,Wright Dave¹⁵,Yaron Yuval¹⁶

Affiliation:

1. Department of Genetics and Genome Sciences; University of Connecticut Health Center; Farmington CT USA

2. Prenatal Diagnosis Unit, Institute of Gynecology, Obstetrics and Neonatology, Hospital Clinic, Maternitat Campus; University of Barcelona Medical School; Catalonia Spain

3. Department of Chemical Pathology; The Chinese University of Hong Kong, Prince of Wales Hospital; Hong Kong

4. Department of Obstetrics and Gynecology; Columbia University Medical Center; New York NY USA

5. Department of Obstetrics and Gynecology; University of Pennsylvania; Philadelphia PA USA

6. Department of Human Genetics; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

7. Department of Obstetrics and Gynecology; Albert Einstein College of Medicine; New York NY USA

8. Genetics Program; North York General Hospital; Toronto ON Canada

9. Department of Obstetrics and Gynecology; University of Calgary; Calgary AB Canada

10. Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

11. Department of Obstetrics and Gynecology; Stanford University School of Medicine; Stanford CA USA

12. Department of Obstetrics and Gynecology; University of South Florida; Tampa FL USA

13. Laboratory for Infectious Diseases and Perinatal Screening; National Institute for Public Health and the Environment (RIVM); Bilthoven The Netherlands

14. Prenatal Screening Unit, Clinical Biochemistry Department; Barking Havering & Redbridge University Hospitals, King George Hospital; Goodmayes UK

15. Department of Statistics; University of Exeter; Exeter UK

16. Prenatal Diagnosis Unit, Genetic Institute; Sourasky Medical Center; Tel Aviv Israel

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

Reference71 articles.

1. Chromosomal microarray versus karyotyping for prenatal diagnosis;Wapner;N Engl J Med,2012

2. Association of copy number variants with specific ultrasonographically detected fetal anomalies;Donnelly;Obstet Gynecol,2014

3. Update on procedure-related risks for prenatal diagnosis techniques;Tabor;Fetal Diagn Ther,2010

5. Non-invasive prenatal testing for aneuploidy: current status and future prospects;Benn;Ultrasound Obstet Gynecol,2013

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Trimester Contingent Screening for Aneuploidies with Cell-Free Fetal DNA in Singleton Pregnancies – a Swiss Single Centre Experience;Geburtshilfe und Frauenheilkunde;2024-01

2. Effects of an animated educational video on knowledge of cell-free DNA screening among Thai pregnant women: a randomized control trial;BMC Pregnancy and Childbirth;2023-12-11

3. Prenatal and postnatal genetic testing toward personalized care: The non-invasive perinatal testing;Molecular and Cellular Probes;2023-12

4. A Diagnosis of Maternal 22q Duplication and Mosaic Deletion following Prenatal Cell-Free DNA Screening;Case Reports in Genetics;2023-11-20

5. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-11